These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1592825)

  • 1. Group B streptococcal opacity variants.
    Pincus SH; Cole RL; Wessels MR; Corwin MD; Kamanga-Sollo E; Hayes SF; Cieplak W; Swanson J
    J Bacteriol; 1992 Jun; 174(11):3739-49. PubMed ID: 1592825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of group B streptococcal opacity variants with the host defense system.
    Pincus SH; Cole RL; Kamanga-Sollo E; Fischer SH
    Infect Immun; 1993 Sep; 61(9):3761-8. PubMed ID: 8359897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase Variation of
    Li J; Zhang JR
    Microbiol Spectr; 2019 Jan; 7(1):. PubMed ID: 30737916
    [No Abstract]   [Full Text] [Related]  

  • 4. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
    Segura M
    Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization.
    Weiser JN; Austrian R; Sreenivasan PK; Masure HR
    Infect Immun; 1994 Jun; 62(6):2582-9. PubMed ID: 8188381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci.
    Mancuso G; Tomasello F; von Hunolstein C; Orefici G; Teti G
    Infect Immun; 1994 Jul; 62(7):2748-53. PubMed ID: 8005664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonial opacity variation in Mycoplasma pulmonis.
    Liss A; Heiland RA
    Infect Immun; 1983 Sep; 41(3):1245-51. PubMed ID: 6309666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological and clinical characteristics of Group B Streptococcus isolates causing materno-neonatal infections: high prevalence of CC17/PI-1 and PI-2b sublineage in neonatal infections.
    Lu B; Wu J; Chen X; Gao C; Yang J; Li Y; Wang J; Zeng J; Fang Y; Wang D; Cui Y; Wang L
    J Med Microbiol; 2018 Nov; 67(11):1551-1559. PubMed ID: 30265233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential protein expression in phenotypic variants of Streptococcus pneumoniae.
    Overweg K; Pericone CD; Verhoef GG; Weiser JN; Meiring HD; De Jong AP; De Groot R; Hermans PW
    Infect Immun; 2000 Aug; 68(8):4604-10. PubMed ID: 10899862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci.
    Poyart C; Tazi A; Réglier-Poupet H; Billoët A; Tavares N; Raymond J; Trieu-Cuot P
    J Clin Microbiol; 2007 Jun; 45(6):1985-8. PubMed ID: 17376884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.
    Wessels MR; Rubens CE; Benedí VJ; Kasper DL
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8983-7. PubMed ID: 2554337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.
    Bellais S; Six A; Fouet A; Longo M; Dmytruk N; Glaser P; Trieu-Cuot P; Poyart C
    J Infect Dis; 2012 Dec; 206(11):1745-52. PubMed ID: 23002446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and genetic diversity of group B streptococcus capsular polysaccharides.
    Cieslewicz MJ; Chaffin D; Glusman G; Kasper D; Madan A; Rodrigues S; Fahey J; Wessels MR; Rubens CE
    Infect Immun; 2005 May; 73(5):3096-103. PubMed ID: 15845517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a protective epitope of group B
    Carboni F; Adamo R; Fabbrini M; De Ricco R; Cattaneo V; Brogioni B; Veggi D; Pinto V; Passalacqua I; Oldrini D; Rappuoli R; Malito E; Margarit IYR; Berti F
    Proc Natl Acad Sci U S A; 2017 May; 114(19):5017-5022. PubMed ID: 28439022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of growth in human serum on an acapsular group B Streptococcus mutant.
    Platt MW; Scaletti J; Correa N
    FEMS Immunol Med Microbiol; 1994 Sep; 9(3):245-51. PubMed ID: 7812272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.
    Rubens CE; Wessels MR; Heggen LM; Kasper DL
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7208-12. PubMed ID: 2823254
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Oliver MB; Basu Roy A; Kumar R; Lefkowitz EJ; Swords WE
    mSphere; 2017; 2(6):. PubMed ID: 29152579
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in membrane fluidity and fatty acid composition between phenotypic variants of Streptococcus pneumoniae.
    Aricha B; Fishov I; Cohen Z; Sikron N; Pesakhov S; Khozin-Goldberg I; Dagan R; Porat N
    J Bacteriol; 2004 Jul; 186(14):4638-44. PubMed ID: 15231797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of multidrug resistant group B streptococci with reduced penicillin susceptibility forming small, less hemolytic colonies.
    Banno H; Kimura K; Tanaka Y; Sekizuka T; Kuroda M; Jin W; Wachino JI; Yamada K; Shibayama K; Arakawa Y
    PLoS One; 2017; 12(8):e0183453. PubMed ID: 28817704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing Colony Opacity Variants and Measuring Opacity Variation in Acinetobacter baumannii.
    Anderson SE; Rather PN
    Methods Mol Biol; 2019; 1946():151-157. PubMed ID: 30798552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.